Welcome to LookChem.com Sign In|Join Free
  • or
2',3-dimethoxychalcone is a chemical compound belonging to the chalcone family, characterized by the presence of two methoxy substituents on the phenyl ring. It is known for its potential pharmaceutical properties, including anti-inflammatory and antioxidant activities, and is being studied for its potential use in the treatment of various diseases, such as cancer, diabetes, and cardiovascular disorders. Additionally, it is being investigated for its role in the development of new drugs and treatments, making it a versatile and important chemical with promising pharmacological applications.

75849-05-7

Post Buying Request

75849-05-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

75849-05-7 Usage

Uses

Used in Pharmaceutical Industry:
2',3-dimethoxychalcone is used as a pharmaceutical compound for its potential therapeutic effects in treating various diseases. Its anti-inflammatory and antioxidant properties make it a promising candidate for the development of new drugs and treatments.
Used in Cancer Treatment:
2',3-dimethoxychalcone is used as a potential anticancer agent, as it has been studied for its potential use in the treatment of various types of cancer. Its pharmacological properties may contribute to the development of new cancer therapies.
Used in Diabetes Management:
2',3-dimethoxychalcone is used as a potential treatment for diabetes, as it has been studied for its potential effects on blood sugar regulation and insulin sensitivity, which could help manage and treat the disease.
Used in Cardiovascular Disorders:
2',3-dimethoxychalcone is used as a potential treatment for cardiovascular disorders, as its anti-inflammatory and antioxidant properties may help protect against heart disease and other related conditions.
Used in Drug Development:
2',3-dimethoxychalcone is used as a key component in the development of new drugs and treatments, as its versatile pharmacological properties offer potential applications in various therapeutic areas.

Check Digit Verification of cas no

The CAS Registry Mumber 75849-05-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,5,8,4 and 9 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 75849-05:
(7*7)+(6*5)+(5*8)+(4*4)+(3*9)+(2*0)+(1*5)=167
167 % 10 = 7
So 75849-05-7 is a valid CAS Registry Number.

75849-05-7Relevant academic research and scientific papers

Biological evaluation and synthesis of new pyrimidine-2(1H)-ol/-thiol derivatives derived from chalcones using the solid phase microwave method

Fandakli, Seda,Kahriman, Nuran,Yücel, Tayyibe Beyza,Alpay Karaoglu, ?engül,Yayli, Nurettin

, p. 520 - 535 (2018)

Twenty-five new hydroxy- and methoxy-substituted 4,6-diarylpyrimidin-2(1H)-ol (20–34) and 4,6-diarylpyri-midine-2(1H)-thiol derivatives (35–44) were synthesized from the reaction of the corresponding 1,3-diaryl-2-propene-1-one compounds (1–19) with urea or thiourea using the solid-phase microwave method. All the new synthetic compounds (20–44) were evaluated with regard to their α-glucosidase activity. However, only compounds 22–25, 27, 31, 34, 35, 37, and 40 exhibited a greater inhibitory effect than standard acarbose. The IC50 values of the active compounds ranged between 2.36 and 13.34 μM. The 25 new compounds were also screened for their in vitro pancreatic lipase activity and compounds 20–27 and 35–39 were found to be active. Of these compounds 26, 27, and 39 exhibited the best antilipase activities at concentrations of 0.40 ± 0.06, 0.26 ± 0.07, and 0.29 ± 0.026 μM. All the new compounds (20–44) were evaluated for their in vitro antimicrobial activity for nine test microorganisms. Compounds 20–24 and 35–39 were determined to possess a significant broad spectrum against the gram-positive bacteria Escherichia faecalis, Staphylococcus aureus, and Bacillus cereus among the tested bacterial agents. Compounds 20–24 and 35–39 exhibit the best activity against Mycobacterium smegmatis, with minimum inhibitory concentrations of 62.5–500 μg/mL, indicating their potential use as antituberculous agents.

Intramolecular Alkylation of Phenols. Part 5. A Regiospecific Anionic Ring Closure of Phenols via Quinone Methides

Murphy, William S.,Wattanasin, Sompong

, p. 1567 - 1577 (2007/10/02)

The bis-magnesium salts of the triols (6a) and (6h) cyclise when heated in benzene with high ortho-regiospecificity to the corresponding bis-phenols (7) and (8).The triols (6k) and (6o) under the same conditions cyclise with high para-regiospecificity to the corresponding bis-phenols (7) and (8).Both (6a) and (6h) cyclise via o-quinone methides, and (6k) and (6o) via p-quinone methides.Results from the use of, inter alia, 18-crown-6, indicate that the high ortho-regiospecificity of the cyclisation of (6a) and (6h) is due to intramolecular Mg(II) bridging of the intermediate o-quinone methides.The high para-regiospecificity of cyclisation of (6k) and (6o) is due to steric hindrance towards o-cyclisation of the intermediate p-quinone methides presented by the Mg(II) cation.The unexpected facility with which (6a) and (6k) undergo ring closure is discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 75849-05-7